Feasibility of C-reactive protein point-of-care testing for antibiotic stewardship in rural GP–pharmacy settings
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 20.05.2026. Verfasst von Sajal Kumar Saha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Innovation in Infectious Disease and Immunology Research (CIIDIR), Institute for Mental and Physical Health and Clinical Translation (IMPA…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To assess the feasibility of implementing C-reactive protein point-of-care testing (CRP-PoCT) for patients presenting with respiratory tract infections (RTIs) in primary care.
Design
Feasibility study.
Setting
General practice (GP) and community pharmacy in rural Victoria. Patients (or Participants): Five GPs and a community pharmacist used CRP-PoCT for RTI patients aged 12–65 years for two months between August and December 2023.
Methods
Data on testing, prescribing, and implementation barriers and facilitators were collected from patient records and surveys of GPs and pharmacists. Feasibility outcomes were analyzed using descriptive statistics and content analysis.
Results
Fifty-five patients were screened, with recruitment rates of 87.5% (35/40) in GP clinics and 67% (10/15) in community pharmacies, and a retention rate of 100%. Adherence to the testing protocol was 100% in both settings; however, adherence to the prescribing protocol was 76% in GP practices and 100% in pharmacies. Common RTI symptoms were cough (70%, n = 30), fever (58%, n = 25), and sore throat (44%, n = 19). Antibiotics were prescribed to 36.4% (12/33) of GP patients and 10% (1/10) of pharmacy patients. Pharmacists managed patients with OTC medicines (80%, 8/10) or immediate GP referral (10%, 1/10). CRP-PoCT feasibility was rated highly by GPs [median 6/7 (IQR 4–6)] and moderately by the pharmacist (4/7). Key implementation facilitators identified were nurse/technician support, medicare funding, clear workflows, and GP–pharmacy collaborative practice agreement.
Conclusion
With mitigation of practical challenges, CRP-PoCT can be feasibly implemented in rural GP–pharmacy settings to enhance antibiotic stewardship for acute respiratory infections in primary care.
Autor:innen und Institutionen
- Centre for Innovation in Infectious Disease and Immunology Research (CIIDIR), Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong, VIC, Australia.
- Barwon Southwest Public Health Unit, Geelong, VIC, Australia.
- Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
- Monash University Health Economics Group, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
ORCID-Profile: Sajal Kumar Saha, Oliver Van Hecke, Mary Lou Chatterton
Zitieren
APA
Saha, S. K., Muleme, M., Hecke, O. V., Chatterton, M. L., & Athan, E. (2026). Feasibility of C-reactive protein point-of-care testing for antibiotic stewardship in rural GP–pharmacy settings. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10401
Vancouver
Saha SK, Muleme M, Hecke OV, Chatterton ML, Athan E. Feasibility of C-reactive protein point-of-care testing for antibiotic stewardship in rural GP–pharmacy settings. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10401
BibTeX
@article{Saha2026,
author = {Saha, Sajal Kumar and Muleme, Michael and Hecke, Oliver Van and Chatterton, Mary Lou and Athan, Eugene},
title = {Feasibility of C-reactive protein point-of-care testing for antibiotic stewardship in rural GP–pharmacy settings},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10401}
}
EUVIMED